Lowe KA - Search Results

1

An international assessment of ovarian cancer incidence and mortality.

Lowe KA, Chia VM, Taylor A, O'Malley C, Kelsh M, Mohamed M, Mowat FS, Goff B. Lowe KA, et al. Gynecol Oncol. 2013 Jul;130(1):107-14. doi: 10.1016/j.ygyno.2013.03.026. Epub 2013 Apr 2. Gynecol Oncol. 2013. PMID: 23558050

2

Symptom triggered screening for ovarian cancer: a pilot study of feasibility and acceptability.

Goff BA, Lowe KA, Kane JC, Robertson MD, Gaul MA, Andersen MR. Goff BA, et al. Among authors: lowe ka. Gynecol Oncol. 2012 Feb;124(2):230-5. doi: 10.1016/j.ygyno.2011.10.032. Epub 2011 Nov 6. Gynecol Oncol. 2012. PMID: 22063459 Free PMC article.

3

Factors affecting risk of mortality in women with vaginal cancer.

Shah CA, Goff BA, Lowe K, Peters WA 3rd, Li CI. Shah CA, et al. Obstet Gynecol. 2009 May;113(5):1038-1045. doi: 10.1097/AOG.0b013e31819fe844. Obstet Gynecol. 2009. PMID: 19384118 Free PMC article.

4

The temporal stability of the Symptom Index among women at high-risk for ovarian cancer.

Lowe KA, Andersen MR, Urban N, Paley P, Dresher CW, Goff BA. Lowe KA, et al. Gynecol Oncol. 2009 Aug;114(2):225-30. doi: 10.1016/j.ygyno.2009.03.015. Epub 2009 May 7. Gynecol Oncol. 2009. PMID: 19427026 Free PMC article.

5

Use of a Symptom Index, CA125, and HE4 to predict ovarian cancer.

Andersen MR, Goff BA, Lowe KA, Scholler N, Bergan L, Drescher CW, Paley P, Urban N. Andersen MR, et al. Among authors: lowe ka. Gynecol Oncol. 2010 Mar;116(3):378-83. doi: 10.1016/j.ygyno.2009.10.087. Epub 2009 Nov 28. Gynecol Oncol. 2010. PMID: 19945742 Free PMC article.

6

Involvement in decision-making about treatment and ovarian cancer survivor quality of life.

Andersen MR, Sweet E, Lowe KA, Standish LJ, Drescher CW, Goff BA. Andersen MR, et al. Among authors: lowe ka. Gynecol Oncol. 2012 Mar;124(3):465-70. doi: 10.1016/j.ygyno.2011.10.029. Epub 2011 Oct 29. Gynecol Oncol. 2012. PMID: 22044688 Free PMC article.

7

Value of symptom-triggered diagnostic evaluation for ovarian cancer.

Andersen MR, Lowe KA, Goff BA. Andersen MR, et al. Among authors: lowe ka. Obstet Gynecol. 2014 Jan;123(1):73-79. doi: 10.1097/AOG.0000000000000051. Obstet Gynecol. 2014. PMID: 24463666 Free PMC article.

8

Racial and Ethnic Variability in the Prevalence and Incidence of Comorbidities Associated with Gastric Cancer in the United States.

Lowe KA, Danese MD, Gleeson ML, Langeberg WJ, Ke J, Kelsh MA. Lowe KA, et al. J Gastrointest Cancer. 2016 Jun;47(2):168-81. doi: 10.1007/s12029-016-9809-5. J Gastrointest Cancer. 2016. PMID: 26961791

9

Effects of Demographics and OTC Analgesics on Ovarian Cancer Symptoms.

Lowe KA, Andersen MR, Kane JC, Robertson MD, Goff BA. Lowe KA, et al. J Nurse Pract. 2013 Jan;9(1):28-33. doi: 10.1016/j.nurpra.2012.06.008. J Nurse Pract. 2013. PMID: 26865837 Free PMC article.

10

Dangerous combinations: Ingestible CAM supplement use during chemotherapy in patients with ovarian cancer.

Andersen MR, Sweet E, Lowe KA, Standish LJ, Drescher CW, Goff BA. Andersen MR, et al. Among authors: lowe ka. J Altern Complement Med. 2013 Aug;19(8):714-20. doi: 10.1089/acm.2012.0295. Epub 2013 Feb 27. J Altern Complement Med. 2013. PMID: 23445210 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

85 results

Search Page

Filters